| Hans-Günter Meyer-Thompson | HIV
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Llibre, Josep M et al.
The Lancet , Volume 391 , Issue 10123 , 839 - 849
Abstract
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)33095-7/fulltext